Guangqiang Li
State Key Laboratory Of Bioactive Molecules And Druggability Assessment
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
The iterative shrinkage thresholding algorithm reveals dynamic aging trajectories of human T lymphocytes via multidimensional spectral flow cytometry analysis.
Journal: International immunopharmacology
Published: December 15, 2025
Complement factor D is a drug target for metabolic-associated fatty liver disease.
Journal: Molecular immunology
Published: October 09, 2025
Author Correction: SLMO2 is a potential prognostic and immunological biomarker in human pan-cancer.
Journal: Scientific reports
Published: March 14, 2024
Identification of antiviral RNAi regulators, ILF3/DHX9, recruit at ZIKV stem loop B to protect against ZIKV induced microcephaly.
Journal: Nature communications
Published: September 17, 2023
SLMO2 is a potential prognostic and immunological biomarker in human pan-cancer.
Journal: Scientific reports
Published: June 06, 2023
ANKRD22 promotes resolution of psoriasiform skin inflammation by antagonizing NIK-mediated IL-23 production.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: May 23, 2023
Transcriptome Analysis Identifies Biomarkers for the Diagnosis and Management of Psoriasis Complicated with Depression.
Journal: Clinical, cosmetic and investigational dermatology
Published: April 06, 2023
USP5 promotes breast cancer cell proliferation and metastasis by stabilizing HIF2α.
Journal: Journal of cellular physiology
Published: October 30, 2021
PPP1R14B Is a Prognostic and Immunological Biomarker in Pan-Cancer.
Journal: Frontiers in genetics
Published: August 24, 2021
Last Updated: 09/26/2026